## **Core Concept**
Zellweger syndrome is a rare, congenital disorder characterized by the absence or near-absence of **peroxisomes** in the cells of the body. Peroxisomes are organelles responsible for the breakdown of fatty acids and amino acids. The syndrome is classified under the group of disorders known as **peroxisomal biogenesis disorders (PBDs)**.

## **Why the Correct Answer is Right**
The correct answer involves a defect in the **PEX genes**, which are essential for peroxisome biogenesis. Specifically, Zellweger syndrome is associated with mutations in **PEX1**, which is the most common gene responsible for this condition. The PEX1 gene provides instructions for making a protein that is involved in the early steps of peroxisome formation. Without functional peroxisomes, the body cannot properly break down certain types of fatty acids and amino acids, leading to the accumulation of very-long-chain fatty acids (VLCFAs) and other toxic substances.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not accurately represent the genetic or molecular basis of Zellweger syndrome.
- **Option B:** This option is incorrect as it does not specify the correct gene or mechanism associated with Zellweger syndrome.
- **Option C:** Although **peroxisomal biogenesis** is indeed related to Zellweger syndrome, option C is not provided, making it impossible to evaluate directly. However, any option not directly related to peroxisome biogenesis or PEX genes would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A key clinical feature of Zellweger syndrome is the presence of **elevated levels of very-long-chain fatty acids (VLCFAs)** in the blood, which is a diagnostic hallmark. This condition leads to severe neurological impairment, developmental delays, and distinctive facial features. Early diagnosis through genetic testing or biochemical assays like VLCFA measurement can help in managing the condition.

## **Correct Answer:** C. PEX 1 gene.